voriconazole has been researched along with atazanavir sulfate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fulco, PP; Gibson, JN | 1 |
| Audagnotto, S; Baietto, L; Bonora, S; Calcagno, A; D'Avolio, A; De Rosa, FG; Di Perri, G; Pagani, N; Simiele, M | 1 |
| Bertz, RJ; Brüggemann, RJ; Burger, DM; Chung, E; Colbers, A; Hruska, MW; Sims, K; Uy, J; Vakkalagadda, B; van Schaik, RH; Xu, X; Zhu, L | 1 |
3 other study(ies) available for voriconazole and atazanavir sulfate
| Article | Year |
|---|---|
Concurrent atazanavir and voriconazole in a patient with multidrug-resistant HIV and a mycetoma.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; Drug Resistance, Multiple, Viral; Humans; Male; Middle Aged; Mycetoma; Oligopeptides; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction.
Topics: Adult; Aged; Atazanavir Sulfate; Cytochrome P-450 CYP2C19; Drug Interactions; Female; Genotype; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oligopeptides; Pulmonary Aspergillosis; Pyridines; Ritonavir; Voriconazole | 2014 |
CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
Topics: Adolescent; Adult; Antifungal Agents; Area Under Curve; Atazanavir Sulfate; Cytochrome P-450 CYP2C19; Drug Combinations; Drug Interactions; Female; Genotype; Healthy Volunteers; HIV Protease Inhibitors; Humans; Male; Middle Aged; Ritonavir; Voriconazole; Young Adult | 2017 |